Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Reexamination Certificate
2011-03-22
2011-03-22
Lu, Frank W (Department: 1634)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
C435S006120, C435S091100, C536S023100, C536S024300, C536S024330, C536S025300
Reexamination Certificate
active
07910336
ABSTRACT:
This invention relates to methods of detecting extracellular hTR RNA and hTERT RNA in blood, plasma, serum, and other bodily fluids. The invention thereby provides an aid for the detection, diagnosis, monitoring, treatment, or evaluation of neoplastic disease.
REFERENCES:
patent: 5576178 (1996-11-01), Emanuel et al.
patent: 6329179 (2001-12-01), Kopreski
patent: 6607898 (2003-08-01), Kopreski et al.
patent: 6916634 (2005-07-01), Kopreski
patent: 7163789 (2007-01-01), Chen et al.
patent: 2237589 (1997-05-01), None
patent: 2319709 (1999-08-01), None
patent: 3717212 (1988-08-01), None
patent: 198 04 372 (1999-08-01), None
patent: 0 841 396 (1998-05-01), None
patent: 0 926 245 (1999-06-01), None
patent: 1 158 055 (2001-11-01), None
patent: WO 90/09456 (1990-08-01), None
patent: WO 97/35589 (1997-10-01), None
patent: WO 98/45450 (1998-10-01), None
patent: WO 99/40221 (1999-08-01), None
patent: WO 99/41426 (1999-08-01), None
patent: WO 00/46601 (2000-08-01), None
Tahara et al., Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections. Oncogene, 18, 1561-1567, 1999.
Nakanishi et al., Expression of telomerase catalytic subunit (hTERT) mRNA does not predict survival in patients with transitional cell carcinoma of the upper urinary tract. Mod. Pathol., 14, 1073-1078, 2001.
Schrader et al., The differentiation status of primary gonadal germ cell tumors correlates inversely with telomerase activity and the expression level of the gene encoding the catalytic subunit of telomerase. BMC Cancer, 2, 32, 2002.
Rohde et al., Expression of the Human Telomerase Reverse Transcriptase Is Not Related to Telomerase Activity in Normal and Malignant Renal Tissue. Clinical Cancer Research, 6, 4803-4809, 2000.
Chen et al., Telomerase RNA as a Detection Marker in the Serum of Breast Cancer Patients. Clinical Cancer Research, 6, 3823-3828, 2000.
Real-Time Quantification in Plasma of Human Telomerase Reverse Transcriptase (hTERT) mRNA: A Simple Blood Test to Monitor Disease in Cancer Patient.
Marchese et al., Low Correspondence Between K-ras Mutations in Pancreatic Cancer Tissue and Detection of K-ras Mutations in Circulating DNA. Pancreas, 32, 171-177, 2006.
Mulcahy et al., A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin. Cancer Res., 4, 271-275, Feb. 1998.
Lord et al., Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. Journal of Gastrointestinal Surgery, 4,135-142, Mar.-Apr. 2000.
De Kok et al., Real-time quantification of human telomerase reverse transcriptase mRNA in tumors and healthy tissues. Clin. Chem., 46, 313-318, Mar. 2000. Nakano et al., Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer. Am. J. Pathol., 153, 857-864, 1998.
Deramaudt et al., Mutant KRAS in the initiation of pancreatic cancer. Biochimica et Biophysica Acta, 1756, 97-101, 2005.
Kameshima et al., Expression of telomerase-associated genes: reflection of telomerase activity in gastric cancer? World J. Surg., 25, 285-289, 2001.
Le et al., Identification of Two RNA-binding Proteins Associated with Human Telomerase RNA. Molecular Biology of the Cell, 11, 999-1010, 2000.
Kolquist et al., Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nature Genetics, 19, 182-186, 1998.
Datta at al., Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction,Journal of Clinical Oncology, 12:75-482, (1994).
Feng et al., “The RNA Component of Human Telomerase,”Science, 269:1236-41 (1995).
Keller at al., “Fluorescence-based RT PCR Analysis: Determination of the Ratio of Soluble to Membrane-bound Forms of FcγRIIA Transcripts in Hematopoietic Cell Lines,”PCR Methods and Applications, 3:32-38 (1993).
Lay et al., “Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR,” Clinical Chemistry, 43:12 2262-2267 (1997).
Kopreski et al, “Detection of Tumor Messenger RNA in the Serum of Patients with Malignant Melanoma,”Clinical Cancer Research, 5:1961-65 (Aug. 1999).
Kyo et al., “Expression of Human Telomerase Subunits in Ovarian Malignant, Borderline and Benign Tumors,”Int. J. Cancer, 80:804-9 (1999).
Wieczorek et al., “Diagnostic and Prognostic Value of RNA-Proteolipid in Sera of Patients with Malignant Disorders following Therapy: First Clinical Evaluation of a Novel Tumor Marker,”Cancer Research, 47:6407-6412 (Dec. 1987).
Pfeiderer et al., “Detection of Tumour Cells in Peripheral Blood and Bone Marrow from Ewing Tumour Patients by RT-PCR,”Int. J. Cancer, 64:135-139 (1995).
Komeda et al., “Sensitive Detection of Circulating Hepatocellular Carcinoma Cells in Peripheral Venous Blood,”Cancer, 9:2214-9 (1995).
Boom et al., “Rapid and Simple Method for Purification of Nucleic Acids,”Journal of Clinical Microbiology28:495-503 (1990).
Suehara et al., “Telomerase Activity in Pancreatic Juice Differentiates Ductal Carcinoma from Adenoma and Pancreatitis,”Clin. Cancer Research. 3:2479-83 (Dec. 1997).
Califano et al., “Detection of Telomerase Activity in Oral Rinses from Head and Neck Squamos Cell Carcinoma Patients,”Cancer Research56:5720-22 (Dec. 15, 1996).
Hiyama et al., “Telomerase Activity in Human Breast Tumors,” Journal of National Cancer Institute, 88(2):116-122 (Jan. 17, 1996).
Sommerfield et al., “Telemerase Activity: A Prevalent Marker of Malignant Human Prostate Tissue,”Cancer Research56,218-222 (Jan. 1, 1996).
Nakamura et al., “Telemerase Catalytic Subunit Homologs from Fission Yeast and Human,”Science277:955-959 (Aug. 15, 1997).
Meyerson et al., hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization,Cell90:785-795 (Aug. 22, 1997).
Office Action, Non-Final Rejection mailed on May 9, 2001 for U.S. Appl. No. 09/653,573.
Office Action, Final Rejection mailed on Apr. 11, 2002 for U.S. Appl. No. 09/653,573.
Office Action, Non-Final Rejection mailed on Sep. 11, 2002 for U.S. Appl. No. 09/653,573.
Allan et al. (2001), “Genetic alterations bronchial mucosa and plasma DNA from individuals at high risk of lung cancer.” Int. J. Cancer 91(3): 359-65.
Gocke et al. (2000), “Serum BCL2/IGH DNA in follicular lymphoma patients: a minimal residual disease marker” Leuk. Lymphoma 39(1-2): 165-72.
Ryan et al., (2003), “A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up.” Gut 52: 101-108.
Sorenson et al. (1994), “Soluble normal and mutated DNA sequences from single-copy genes in human blood.” Cancer Epidemol. Biomarkers Prev. 3(1):67-71.
Dasi et al. (2001), “Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA: a simple blood test to monitor disease in cancer patients.” Lab. Invest. 81: 767-9.
Hasselmann et al. (2001), “Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma.” Oncology Reports 8: 115-8.
Miura et al. (2003), “Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma.” Oncology 64: 430-4.
Nakano et al. (1998), “Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer.” Am. J. Pathol. 153(3): 857-64.
Novakovic et al. (2004), “Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer.” Oncology Reports 11: 245-52.
Gocke Christopher D.
Kopreski Michael S.
Lu Frank W
McDonnell & Boehnen Hulbert & Berghoff
OncoMEDx, Inc.
LandOfFree
Method for detection of hTR and hTERT telomerase-associated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for detection of hTR and hTERT telomerase-associated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for detection of hTR and hTERT telomerase-associated... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2702312